A hospital in Israel has successfully created lab-grown kidneys that survived for 34 weeks, marking a major leap in regenerative medicine. This achievement brings us closer to addressing the global organ shortage by potentially enabling functional, lab-grown organs for human transplants in the future.
With further refinement and testing, these lab-grown kidneys could transform outcomes for patients with end-stage renal disease making organ donations less essential and saving countless lives.
When do you think lab-grown organs like these might move from research to real-world transplants and what challenges do you see along the way?
This breakthrough is truly exciting and gives hope to many kidney patients. Lab-grown kidneys surviving 34 weeks is a big step, but moving to real-world transplants will take more time. Scientists still need to test safety, long-term function, and immune response. Challenges include making sure the organs work like natural ones and don’t get rejected by the body. Also, scaling up production for many patients is not easy. Maybe in the next 10–15 years, we’ll see clinical trials and slow adoption.
Lab-grown organs like these could reach real-world transplants in the next 10–15 years, depending on progress in safety, functionality, and regulatory approval. Key challenges include ensuring long-term survival and function in the human body, avoiding immune rejection, scaling up production, and meeting strict clinical standards. Still, this breakthrough offers real hope and the future of transplant medicine is definitely changing.
It will be a major breakthrough in the medical field. Transplantion would become easier and common people can afford it. Rejection of grafts would be lesser too , if its made in such a way that it suppresses the immune system of the reciever.
This breakthrough in lab-grown kidneys gives real hope to patients with kidney failure. If successful, it could reduce the need for organ donations and change the lives of countless patients and their families for the better.
If the clinical trials prove to be successful, it will be a boon for patients suffering from end-stage renal disease. Currently, there is a severe shortage of organ donors, and the waiting list for recipients is growing. This discovery could offer hope to many patients, helping them return to normal life.
This breakthrough is a huge step toward solving the organ shortage crisis. If research continues to progress, we may see lab-grown organs in clinical use within the next 10–15 years. The biggest challenges ahead are ensuring long-term safety, preventing rejection, scaling production, and keeping costs accessible. If we overcome these, lab-grown kidneys could truly transform transplant medicine.
This is an incredible milestone. Keeping lab-grown kidneys alive for 34 weeks shows how close regenerative medicine is to changing transplant care. If this progress continues, we may see early human applications within the next decade, though full clinical use will likely take longer.
Amazing discovery! The 34-week survival of lab-grown kidneys is a significant step in the fight against the world’s organ shortage. Although there are still obstacles to overcome, such as ensuring long-term functionality, immune compatibility, ethical regulation, and large-scale production, I think clinical applications could appear within the next ten years. Still, this fusion of biology and biotechnology offers immense hope — a future where no life is lost waiting for a donor organ feels closer than ever.
The 34-week survival of lab-grown kidneys is a significant step in the fight against the world’s organ shortage. Although there are still obstacles to overcome, such as ensuring long-term functionality, immune compatibility, ethical regulation, and large-scale production, I think clinical applications could appear within the next ten years. Still, this fusion of biology and biotechnology offers immense hope — a future where no life is lost waiting for a donor organ feels closer than ever. 
